February 2024

Digital Biomarkers & Alzheimer’s Research: Q&A with Liam Kaufman, VP of Clinical Sciences

Kaufman discusses the ways the digital biomarkers are improving Alzheimer’s research by directly tackling some of the unique challenges that researchers face. by Mike HollanOriginally published on PharmExec.com Researching and developing treatments for Alzheimer’s disease comes with unique challenges, due to the nature of the disease. Liam Kaufman, VP of clinical sciences at Cambridge Cognition, spoke […]

Digital Biomarkers & Alzheimer’s Research: Q&A with Liam Kaufman, VP of Clinical Sciences Read More »

Cambridge Cognition and ActiGraph announce partnership to accelerate central nervous system trials

by ActiGraph PENSACOLA, FL, February 20, 2024 – ActiGraph and Cambridge Cognition, leading providers of wearable digital health technologies and CNS assessments, respectively, announced a new strategic partnership to deliver a broad suite of assessments to provide a fully-rounded view of mental and physical capabilities. The companies’ technologies have been used together by top 20

Cambridge Cognition and ActiGraph announce partnership to accelerate central nervous system trials Read More »

Cambridge Cognition’s Global Teams Unite for Mental Health Causes! 

Cambridge Cognition unveils strategic partnership for Chinese market expansion Cambridge Cognition is pleased to announce an expansion in the Chinese market through a strategic partnership with Luca Healthcare Limited, a category leader in digital screening, treatment and management tools in China. Cambridge Cognition has signed an exclusive licencing agreement with Luca Healthcare

Cambridge Cognition’s Global Teams Unite for Mental Health Causes!  Read More »

Scroll to Top